Brickell Biotech, a US–based developer of drug therapies for the treatment of skin diseases, has raised $7m in its series B round led by South Korea-based cosmetics maker AmorePacific’s corporate venturing unit. Alongside AmorePacific Ventures in the B round was venture capital firm Palisade Capital Management’s Concentrated Equity Partnership II fund. In July 2010, Brickell… Continue reading AmorePacific goes skin-deep
Month: February 2013
Windeln.de kits out with €15m
Windeln.de, Germany-based online baby goods retailer owned by Urban-Brand, has raised €15m ($20m) after shaowing annualized sales of €50m. Venture capital firms 360 Capital Partners and MCI Management joined the consortium as new investors along with peers and existing shareholders Acton Capital Partners and DN Capital. In February 2012, Windeln raised “a high seven-figure amount”… Continue reading Windeln.de kits out with €15m
Strategics weave way into FibeRio
FibeRio, a US-based developer and manufacturer of a nonwoven material, has raised $13m from two strategic investors. Saudi Basic Industries Corporation’s corporate venturing unit, Sabic Ventures, and Aster Capital Partners, a multi-corporate venturing fund sponsored by France-based industrial group Solvay, Schneider Electric and Alstom, led the investment in FibeRio. James Wilson, of Sabic’s Innovative Plastics… Continue reading Strategics weave way into FibeRio
Inkef monkeys around with Sapiens
Sapiens Steering Brain Stimulation, a Netherlands-based medical technology company spun off from local conglomerate Royal Philips Electronics in 2011, has extended its series A round by €7.5m ($10m) for its deep-brain stimulation (DBS) implant to treat Parkinson’s disease. Inkef Capital, a quasi-corporate venturing joint venture between pension funds ABP and Omers, joined Sapiens’ consortium in… Continue reading Inkef monkeys around with Sapiens
SocialFlow targeting $10m
In April 2011, SocialFlow raised $7m in its series A round from a consortium of publishers.
Anaplan raises $11.4m
Anaplan, a US-based provider of enterprise performance applications, has raised $11.4m in its series B round from existing investors and venture capital firms Granite Ventures and Shasta Ventures. Software provider Salesforce is understood to be an investor in Anaplan as its Adrian Kunzle is on Anaplan’s board. Anaplan has raised more than $17.5m.
Reading the runes from Newport Beach
The Corporate Venturing and Innovation Partnering Conference in Newport Beach last week provided a decent summary of what the corporate venturing world is thinking about as it enjoys a period of rapid growth.
Big Deal: energy and data rise
As demand for energy resources and data continues to grow, venture investors in both sectors are finding more of their time is being spent looking at how they can store and use the units produced leading to multiple Big Deals this past week. In information technology (IT), Skyera, a US-based data storage provider, raised $45.6m… Continue reading Big Deal: energy and data rise
Lux wears down oil industry
UK-based corrosion prevention company Lux Assure has raised £3.25m ($5m) from a corporate venturing-led consortium to “transform the business from a technology development business to a service provider for the oil and gas industry”. US-based oil major ConocoPhillips, Norway-based peer Statoil’s Technology Invest unit, angel network Archangel Informal Investment, and the Scottish Investment Bank (SIB),… Continue reading Lux wears down oil industry
Cintrifuse commits to Allos
Cintrifuse, a corporate-backed $100m fund of funds in Cincinnati, Ohio, has committed to Allos Ventures. In January, US-based consumer goods maker Proctor and Gamble, whose former head of innovation, Jeffrey Weedman, now runs Cintrifuse, retailer Macy’s, the University of Cincinnati and local utility Duke Energy backed Cintrifuse.
FVCG bleeds into Actinobac
The portfolio company has exclusive rights to the therapeutic use of Leukothera, which targets Leukocyte Function Antigen-1 (LFA-1) on white blood cells, through a license from the University of Medicine and Dentistry of New Jersey.
Baidu tastes Tapas
News provider Sina Tech said Baidu had a controlling stake in Tapas, a mobile phone operating system, and in Dianxin, according to data provider Zero2IPO.
CDRD Ventures links with Pfizer
Through this collaboration, the two organisations will mutually-selected CVI research and development projects with the goal of commercializing them and resulting intellectual property.
Euclid analyses $17.3m
Euclid, a US-based provider of real-world shopper analytics, has raised $17.3m from a consortium including Novel TMT Ventures, a subsidiary of Novel TMT, the technology, media and telecom investment unit of the Hong Kong-based Novel Group. Euclid’s round was led by venture capital firm Benchmark Capital with participation from peers NEA, Ulu Ventures, XG Ventures,… Continue reading Euclid analyses $17.3m